Eye study underscores the long-lasting benefits of controlling diabetes

NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control. Eye study underscores the long-lasting benefits of controlling diabetes


People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy. Investigators who led the ACCORD Follow-on Eye Study (ACCORDION) announced the results today in New Orleans at the American Diabetes Association annual meeting. The study was supported by the National Institutes of Health’s National Eye Institute (NEI).
“This study sends a powerful message to people with type 2 diabetes who worry about losing vision,” said Emily Chew, M.D., deputy director of the NEI Division of Epidemiology and Clinical Applications and lead author of the study report, published online today in Diabetes Care. “Well-controlled glycemia, or blood sugar level, has a positive, measurable, and lasting effect on eye health.”
A complication of diabetes, diabetic retinopathy can damage tiny blood vessels in the retina — the light-sensitive tissue in the back of the eye……..
Read more: http://www.eurekalert.org/pub_releases/2016-06/nei-esu060916.php
Source: Eureka Alert